The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Pharmacology
(Jan 2022)
3-OBA Is Not an Antagonist of GPR81
Mohammad Ali Mohammad Nezhady,
Mohammad Ali Mohammad Nezhady,
Sylvain Chemtob,
Sylvain Chemtob
Affiliations
Mohammad Ali Mohammad Nezhady
Programmes en Biologie Moléculaire, Faculté de Médecine, Université de Montréal, Montreal, QC, Canada
Mohammad Ali Mohammad Nezhady
Centre de Recherche du CHU Sainte-Justine, Montreal, QC, Canada
Sylvain Chemtob
Programmes en Biologie Moléculaire, Faculté de Médecine, Université de Montréal, Montreal, QC, Canada
Sylvain Chemtob
Centre de Recherche du CHU Sainte-Justine, Montreal, QC, Canada
DOI
https://doi.org/10.3389/fphar.2021.803907
Journal volume & issue
Vol. 12
Abstract
Read online
No abstracts available.
Keywords
GPR81
lactate
3-hydroxy-butyrate acid
antagonist
signalling
WeChat QR code
Close